Clinical Trial Update: Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating Apatinib in advanced osteosarcoma after failure of standard multimodal therapy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: GUO WEI | Conditions: Osteosarcoma, Metastasis | Phase 2, Phase 3 | Status: COMPLETED